36
Participants
Start Date
September 5, 2019
Primary Completion Date
January 11, 2023
Study Completion Date
January 11, 2023
HemoCare™ Hemodialysis System
The HemoCare™ Hemodialysis System is intended for hemodialysis treatment, including short daily and nocturnal hemodialysis, of renal failure patients. The HemoCare™ Hemodialysis System is intended for use in chronic dialysis facilities, self-care dialysis facilities, or the home setting. All treatments must be prescribed by a physician and administered by a trained operator. Treatments must be performed under the supervision or assistance of a medical professional or a care partner who has been trained and deemed competent in the use of the device by the prescribing physician.
The Rogosin Institute, New York
University of Virginia, Charlottesville
Dialysis Clinic, Inc., Nashville
Dialysis Clinic Inc. - Knoxville, Knoxville
University of Mississippi Medical Center, Jackson
Wellbound South Austin, Austin
Wellbound North Austin, Austin
Dialysis Clinic, Inc - NJ, North Brunswick
Lead Sponsor
CVS Kidney Care LLC.
UNKNOWN
Deka Research and Development
INDUSTRY